BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 29685074)

  • 21. Neurofibromatosis type I: mutation spectrum of NF1 in spanish patients.
    Palma Milla C; Lezana Rosales JM; López Montiel J; Andrés Garrido LD; Sánchez Linares C; Carmona Tamajón S; Torres Fernández C; Sánchez González P; Franco Freire S; Benito López C; López Siles J
    Ann Hum Genet; 2018 Nov; 82(6):425-436. PubMed ID: 30014477
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Seizures in neurofibromatosis. What is the risk?].
    Drouet A
    Rev Neurol (Paris); 2011 Dec; 167(12):886-96. PubMed ID: 22041820
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optimizing biologically targeted clinical trials for neurofibromatosis.
    Gutmann DH; Blakeley JO; Korf BR; Packer RJ
    Expert Opin Investig Drugs; 2013 Apr; 22(4):443-62. PubMed ID: 23425047
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic diagnosis of neurofibromatosis type 1: targeted next- generation sequencing with Multiple Ligation-Dependent Probe Amplification analysis.
    Wu-Chou YH; Hung TC; Lin YT; Cheng HW; Lin JL; Lin CH; Yu CC; Chen KT; Yeh TH; Chen YR
    J Biomed Sci; 2018 Oct; 25(1):72. PubMed ID: 30290804
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NF1 molecular characterization and neurofibromatosis type I genotype-phenotype correlation: the French experience.
    Sabbagh A; Pasmant E; Imbard A; Luscan A; Soares M; Blanché H; Laurendeau I; Ferkal S; Vidaud M; Pinson S; Bellanné-Chantelot C; Vidaud D; Parfait B; Wolkenstein P
    Hum Mutat; 2013 Nov; 34(11):1510-8. PubMed ID: 23913538
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mouse models of neurofibromatosis 1 and 2.
    Gutmann DH; Giovannini M
    Neoplasia; 2002; 4(4):279-90. PubMed ID: 12082543
    [TBL] [Abstract][Full Text] [Related]  

  • 27. COVID-19 in people with neurofibromatosis 1, neurofibromatosis 2, or schwannomatosis.
    Banerjee J; Friedman JM; Klesse LJ; Yohay KH; Jordan JT; Plotkin SR; Allaway RJ; Blakeley JO
    Genet Med; 2023 Feb; 25(2):100324. PubMed ID: 36565307
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic advances for the tumors associated with neurofibromatosis type 1, type 2, and schwannomatosis.
    Blakeley JO; Plotkin SR
    Neuro Oncol; 2016 May; 18(5):624-38. PubMed ID: 26851632
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutation spectrum of NF1 and clinical characteristics in 78 Korean patients with neurofibromatosis type 1.
    Ko JM; Sohn YB; Jeong SY; Kim HJ; Messiaen LM
    Pediatr Neurol; 2013 Jun; 48(6):447-53. PubMed ID: 23668869
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidence of tethered cord syndrome in neurofibromatosis types 1 and 2 pediatric patients: a population-level analysis.
    Bhanja D; Freedman Z; Sciscent BY; Moeckel C; Daggubati L; Rizk E
    Childs Nerv Syst; 2024 Jun; 40(6):1821-1825. PubMed ID: 38451296
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preimplantation diagnosis for neurofibromatosis.
    Verlinsky Y; Rechitsky S; Verlinsky O; Chistokhina A; Sharapova T; Masciangelo C; Levy M; Kaplan B; Lederer K; Kuliev A
    Reprod Biomed Online; 2002; 4(3):218-22. PubMed ID: 12709270
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Congenital Retroperitoneal Teratoma in Neurofibromatosis Type 1.
    Yap P; Super L; Qin J; Burgess T; Prodanovic Z; Edwards C; Thomas R; Carpenter K; Tan TY
    Pediatr Blood Cancer; 2016 Apr; 63(4):706-8. PubMed ID: 26514327
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutational Spectrum and Genotype-phenotype Correlations in Neurofibromatosis Type 1 Patients from North Macedonia: Identification of Ten Novel
    Gjorgjievska M; Bozhinovski G; Sukarova-Angelovska E; Kocova M; Kanzoska LM; Plaseska-Karanfilska D
    Balkan Med J; 2023 Jul; 40(4):252-261. PubMed ID: 37073110
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neurofibromatosis from Head to Toe: What the Radiologist Needs to Know.
    Wang MX; Dillman JR; Guccione J; Habiba A; Maher M; Kamel S; Panse PM; Jensen CT; Elsayes KM
    Radiographics; 2022; 42(4):1123-1144. PubMed ID: 35749292
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical Presentation and Novel Pathogenic Variants among 68 Chinese Neurofibromatosis 1 Children.
    Yao R; Yu T; Xu Y; Yu L; Wang J; Wang X; Wang J; Shen Y
    Genes (Basel); 2019 Oct; 10(11):. PubMed ID: 31717729
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Somatic Mosaicism of NF2 Gene Mutation with Constitutional NF1 Gene Mutation in Neurofibromatosis Type 2: a Case Report.
    Yoo SJ; Hwang YS
    Clin Lab; 2020 Nov; 66(11):. PubMed ID: 33180429
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neurofibromatosis type 2 French cohort analysis using a comprehensive NF2 molecular diagnostic strategy.
    Pasmant E; Louvrier C; Luscan A; Cohen J; Laurendeau I; Vidaud M; Vidaud D; Goutagny S; Kalamarides M; Parfait B
    Neurochirurgie; 2018 Nov; 64(5):335-341. PubMed ID: 26073919
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic Analyses of the
    Ulusal SD; Gürkan H; Atlı E; Özal SA; Çiftdemir M; Tozkır H; Karal Y; Güçlü H; Eker D; Görker I
    Balkan J Med Genet; 2017 Jun; 20(1):13-20. PubMed ID: 28924536
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and molecular characterization of 112 single-center patients with Neurofibromatosis type 1.
    Corsello G; Antona V; Serra G; Zara F; Giambrone C; Lagalla L; Piccione M; Piro E
    Ital J Pediatr; 2018 Apr; 44(1):45. PubMed ID: 29618358
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurofibromatosis 1 and neurofibromatosis 2: a twenty first century perspective.
    Ferner RE
    Lancet Neurol; 2007 Apr; 6(4):340-51. PubMed ID: 17362838
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.